EXICURE, INC. Share Price
EXICURE, INC. (XCUR) had Share Price of $7.90 per share as of 2023-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2024-11-14
- 2023-09-30: Share Price $7.90; Share Price as first filed $1.58.
- 2023-06-30: Share Price $1.58.
- 2023-03-31: Share Price $1.58.
- 2019-03-31: Share Price $2.80.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2023-09-30 | $7.90 10-Q · filed 2024-11-14 | $1.58 10-Q · filed 2024-05-16 |
| 2023-06-30 | $1.58 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $1.58 10-Q · filed 2024-06-17 | |
| 2019-03-31 | $2.80 10-Q · filed 2020-05-14 | |
| 2018-03-31 | $3.00 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $4.21 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | $4.21 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $4.21 10-Q · filed 2018-08-06 | |
| 2017-03-31 | $4.21 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |